Sippl C - Search Results

1

RB1‑promoter methylation in glioblastoma: A rare event in glioblastoma.

Urbschat S, Breitfelder G, Henia M, Schulz-Schaeffer W, Sippl C, Oertel J, Ketter R. Urbschat S, et al. Among authors: sippl c. Oncol Rep. 2023 Jul;50(1):143. doi: 10.3892/or.2023.8580. Epub 2023 Jun 2. Oncol Rep. 2023. PMID: 37264960 Free PMC article.

2

Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas.

Sippl C, Urbschat S, Kim YJ, Senger S, Oertel J, Ketter R. Sippl C, et al. Oncol Lett. 2018 Feb;15(2):1600-1606. doi: 10.3892/ol.2017.7490. Epub 2017 Nov 24. Oncol Lett. 2018. PMID: 29434855 Free PMC article.

3

The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme.

Sippl C, Teping F, Ketter R, Braun L, Tremmel L, Schulz-Schaeffer W, Oertel J, Urbschat S. Sippl C, et al. World Neurosurg. 2019 Dec;132:e900-e908. doi: 10.1016/j.wneu.2019.07.134. Epub 2019 Jul 24. World Neurosurg. 2019. PMID: 31351207

4

Bisulfite profiling of the MGMT promoter and comparison with routine testing in glioblastoma diagnostics.

Tierling S, Jürgens-Wemheuer WM, Leismann A, Becker-Kettern J, Scherer M, Wrede A, Breuskin D, Urbschat S, Sippl C, Oertel J, Schulz-Schaeffer WJ, Walter J. Tierling S, et al. Among authors: sippl c. Clin Epigenetics. 2022 Feb 18;14(1):26. doi: 10.1186/s13148-022-01244-4. Clin Epigenetics. 2022. PMID: 35180887 Free PMC article.

5

Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy.

Urbschat S, Sippl C, Engelhardt J, Kammers K, Oertel J, Ketter R. Urbschat S, et al. Among authors: sippl c. Mol Cytogenet. 2017 May 4;10:16. doi: 10.1186/s13039-017-0317-5. eCollection 2017. Mol Cytogenet. 2017. PMID: 28484518 Free PMC article.

6

miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme.

Sippl C, Ketter R, Braun L, Teping F, Schoeneberger L, Kim YJ, List M, Nakhoda A, Wemmert S, Oertel J, Urbschat S. Sippl C, et al. Acta Neurochir (Wien). 2019 Nov;161(11):2299-2309. doi: 10.1007/s00701-019-04051-8. Epub 2019 Sep 2. Acta Neurochir (Wien). 2019. PMID: 31478117

7

MiRNA-181d Expression Correlates in Tumor versus Plasma of Glioblastoma Patients-the Base of a Preoperative Stratification Tool for Local Carmustine Wafer Use.

Sippl C, Quiring A, Teping F, Schulz-Schaeffer W, Urbschat S, Ketter R, Oertel J. Sippl C, et al. World Neurosurg. 2022 Mar;159:e324-e333. doi: 10.1016/j.wneu.2021.12.053. Epub 2021 Dec 20. World Neurosurg. 2022. PMID: 34942386

8

MiRNA-181d Expression Significantly Affects Treatment Responses to Carmustine Wafer Implantation.

Sippl C, Ketter R, Bohr L, Kim YJ, List M, Oertel J, Urbschat S. Sippl C, et al. Neurosurgery. 2019 Jul 1;85(1):147-155. doi: 10.1093/neuros/nyy214. Neurosurgery. 2019. PMID: 29846701

9

The Loss of 1p as a Reliable Marker of Progression in a Child with Aggressive Meningioma: A 16-Year Follow-Up Case Report.

Hemmer S, Sippl C, Sahm F, Oertel J, Urbschat S, Ketter R. Hemmer S, et al. Among authors: sippl c. Pediatr Neurosurg. 2020;55(6):418-425. doi: 10.1159/000512001. Epub 2020 Dec 9. Pediatr Neurosurg. 2020. PMID: 33296905 Free article.

10

Motor skills, cognitive impairment, and quality of life in normal pressure hydrocephalus: early effects of shunt placement.

Hülser M, Spielmann H, Oertel J, Sippl C. Hülser M, et al. Among authors: sippl c. Acta Neurochir (Wien). 2022 Jul;164(7):1765-1775. doi: 10.1007/s00701-022-05149-2. Epub 2022 Feb 25. Acta Neurochir (Wien). 2022. PMID: 35212797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters